Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP testinG, of Heart Failure Therapies

NCT03412201 is registered in ClinicalTrials.gov with Heart Initiative as lead sponsor.

NCT NCT03412201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03412201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP testinG, of Heart Failure Therapies
Lead sponsor
Heart Initiative
Phase
Not applicable
Overall status
Unknown status
Start date
May 11, 2018
Completion date
October 31, 2021
Enrollment
1,800 (estimated)
Sites
78

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure